Research Article

You have full text access to this OnlineOpen article

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

  1. K. N. Verpoort*,
  2. C. M. Jol-van der Zijde,
  3. E. A. M. Papendrecht-van der Voort,
  4. A. Ioan-Facsinay,
  5. J. W. Drijfhout,
  6. M. J. D. van Tol,
  7. F. C. Breedveld,
  8. T. W. J. Huizinga,
  9. R. E. M. Toes

Article first published online: 28 NOV 2006

DOI: 10.1002/art.22279

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 12, pages 3799–3808, December 2006

Additional Information

How to Cite

Verpoort, K. N., Jol-van der Zijde, C. M., Papendrecht-van der Voort, E. A. M., Ioan-Facsinay, A., Drijfhout, J. W., van Tol, M. J. D., Breedveld, F. C., Huizinga, T. W. J. and Toes, R. E. M. (2006), Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis & Rheumatism, 54: 3799–3808. doi: 10.1002/art.22279

Author Information

  1. Leiden University Medical Center, Leiden, The Netherlands

*Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands

Publication History

  1. Issue published online: 28 NOV 2006
  2. Article first published online: 28 NOV 2006
  3. Manuscript Accepted: 11 SEP 2006
  4. Manuscript Received: 19 MAY 2006

Funded by

  • Dutch Arthritis Association
  • Gratama Foundation
  • Leiden University Fund
  • Autocure European Consortium
  • Vidi grant from The Netherlands Organization for Scientific Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lara Valor, Inmaculada de la Torre Ortega, ¿Debemos usar los factores de mal pronóstico para iniciar precozmente un tratamiento biológico en los pacientes con artritis reumatoide?, Reumatología Clínica, 2012,

    CrossRef

  2. 2
    Joyce JBC van Beers, Annemiek Willemze, Judith Stammen-Vogelzangs, Jan W Drijfhout, René EM Toes, Ger J M Pruijn, Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles, Arthritis Research & Therapy, 2012, 14, 1, R35

    CrossRef

  3. 3
    D. P. C. de Rooy, J. Kalvesten, T. W. J. Huizinga, A. H. M. van der Helm-van Mil, Loss of metacarpal bone density predicts RA development in recent-onset arthritis, Rheumatology, 2012,

    CrossRef

  4. 4
    Annemiek Willemze, Leendert A. Trouw, René E. M. Toes, Tom W. J. Huizinga, The influence of ACPA status and characteristics on the course of RA, Nature Reviews Rheumatology, 2012, 8, 3, 144

    CrossRef

  5. 5
    Peter Taylor, Juliane Gartemann, Jeanie Hsieh, James Creeden, A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis, Autoimmune Diseases, 2011, 2011, 1

    CrossRef

  6. 6
    Hans Ulrich Scherer, Gerd-Rüdiger Burmester, Adaptive immunity in rheumatic diseases – Bystander or pathogenic player?, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 785

    CrossRef

  7. 7
    Parawee Suwannalai, Leendert A. Trouw, Rene E. M. Toes, Tom W. J. Huizinga, Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis, Modern Rheumatology, 2011, 22, 1, 15

    CrossRef

  8. 8
    F. Pratesi, C. Tommasi, C. Anzilotti, I. Puxeddu, E. Sardano, G. Di Colo, P. Migliorini, Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies, Clinical & Experimental Immunology, 2011, 164, 3
    Direct Link:
  9. 9
    R.A. Benson, A. Patakas, R. McQueenie, K. Ross, I.B. McInnes, J.M. Brewer, P. Garside, Arthritis in space and time – To boldly go!, FEBS Letters, 2011, 585, 23, 3640

    CrossRef

  10. 10
    Jezabel Varadé, Ma Ángeles Figueredo, Sara Cano, Manuel Fuentes, Emilio Gómez De La Concha, Benjamín Fernández-Gutiérrez, Elena Urcelay, Ma Carmen Martin, Association between shared epitope and anti-citrullinated peptide antibodies in rheumatoid arthritis: A systematic review and meta-analysis, Inmunología, 2011, 30, 4, 119

    CrossRef

  11. 11
    María de Gracia Villa, Cecilia Jiménez-Jorquera, Isabel Haro, Maria José Gomara, Raimon Sanmartí, César Fernández-Sánchez, Ernest Mendoza, Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis, Biosensors and Bioelectronics, 2011, 27, 1, 113

    CrossRef

  12. 12
    Chunhua Xun, Yong Zhao, Comparison of serological markers between ACPA+ and ACPA− of RA patients, Rheumatology International, 2011,

    CrossRef

  13. 13
    Nina A. Daha, Nirmal K. Banda, Anja Roos, Frank J. Beurskens, Joost M. Bakker, Mohamed R. Daha, Leendert A. Trouw, Complement activation by (auto-) antibodies, Molecular Immunology, 2011, 48, 14, 1656

    CrossRef

  14. 14
    Jian YIN, Ting LI, Jun BAO, Hu-ji XU, Detection of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis: the clinical significance, Academic Journal of Second Military Medical University, 2011, 31, 9, 1023

    CrossRef

  15. 15
    Brooke E Gilliam, Melinda R Reed, Anil K Chauhan, Amanda B Dehlendorf, Terry L Moore, Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis, Pediatric Rheumatology, 2011, 9, 1, 8

    CrossRef

  16. 16
    Omri Snir, Mary Rieck, John A. Gebe, Betty B. Yue, Crystal A. Rawlings, Gerald Nepom, Vivianne Malmström, Jane H. Buckner, Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA–DRB1*0401–positive humanized mice and rheumatoid arthritis patients, Arthritis & Rheumatism, 2011, 63, 10
    Direct Link:
  17. 17
    Marc K. Jenkins, Daniel Mueller, On the trail of arthritogenic T cells, Arthritis & Rheumatism, 2011, 63, 10
    Direct Link:
  18. 18
    Parawee Suwannalai, Annemiek Willemze, Linda van Toorn, Gerrie Stoeken-Rijsbergen, Nivine Levarht, Jan Drijfhout, Tom W J Huizinga, Rene E M Toes, Leendert A Trouw, The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA, Arthritis Research & Therapy, 2011, 13, 6, R195

    CrossRef

  19. 19
    R. Klaasen, T. Cantaert, C. A. Wijbrandts, C. Teitsma, D. M. Gerlag, T. A. Out, M. J. de Nooijer, D. Baeten, P. P. Tak, The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study, Rheumatology, 2011, 50, 8, 1487

    CrossRef

  20. 20
    Omri Snir, Mona Widhe, Monika Hermansson, Caroline von Spee, Johan Lindberg, Sanne Hensen, Karin Lundberg, Åke Engström, Patrick J. W. Venables, René E. M. Toes, Rikard Holmdahl, Lars Klareskog, Vivianne Malmström, Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  21. 21
    Natalia Wegner, Karin Lundberg, Andrew Kinloch, Benjamin Fisher, Vivianne Malmström, Marc Feldmann, Patrick J. Venables, Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis, Immunological Reviews, 2010, 233, 1
    Direct Link:
  22. 22
    Kevin D. Deane, Jill M. Norris, V. Michael Holers, Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for Investigation, Rheumatic Disease Clinics of North America, 2010, 36, 2, 213

    CrossRef

  23. 23
    Alexei von Delwig, James Locke, John H. Robinson, Wan-Fai Ng, Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  24. 24
    David L Scott, Frederick Wolfe, Tom WJ Huizinga, Rheumatoid arthritis, The Lancet, 2010, 376, 9746, 1094

    CrossRef

  25. 25
    Antonio Manzo, Michele Bombardieri, Frances Humby, Costantino Pitzalis, Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling, Immunological Reviews, 2010, 233, 1
    Direct Link:
  26. 26
    L. A. Trouw, E. M. Haisma, E. W. N. Levarht, D. van der Woude, A. Ioan-Facsinay, M. R. Daha, T. W. J. Huizinga, R. E. Toes, Anti–cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways, Arthritis & Rheumatism, 2009, 60, 7
    Direct Link:
  27. 27
    H. Ulrich Scherer, Jun Wang, René E. M. Toes, Diane van der Woude, Carolien A. M. Koeleman, Arjen R. de Boer, Tom W. J. Huizinga, André M. Deelder, Manfred Wuhrer, Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum, PROTEOMICS - Clinical Applications, 2009, 3, 1
    Direct Link:
  28. 28
    Hani El-Gabalawy, The preclinical stages of RA: lessons from human studies and animal models, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 49

    CrossRef

  29. 29
    Michael P. M. van der Linden, Diane van der Woude, Andreea Ioan-Facsinay, E. W. Nivine Levarht, Gerrie Stoeken-Rijsbergen, Tom W. J. Huizinga, René E. M. Toes, Annette H. M. van der Helm-van Mil, Value of anti–modified citrullinated vimentin and third-generation anti–cyclic citrullinated peptide compared with second-generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 8
    Direct Link:
  30. 30
    Tom W.J. Huizinga, Ferdinand C. Breedveld, Rheumatoid Arthritis, 2009,

    CrossRef

  31. 31
    Lisiane Maria Enriconi dos Anjos, Ivanio Alves Pereira, Eleonora d ‘Orsi, Andrea Piette Seaman, Rufus Watson Burlingame, Edelton Flavio Morato, A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis, Clinical Rheumatology, 2008, 28, 2, 153

    CrossRef

  32. 32
    Walther J. Van Venrooij, Joyce J.B.C. Van Beers, Ger J.M. Pruijn, Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis, Annals of the New York Academy of Sciences, 2008, 1143, 1
    Direct Link:
  33. 33
    R. Engelmann, J. Brandt, M. Eggert, K. Karberg, A. Krause, G. Neeck, B. Mueller-Hilke, IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA, Rheumatology, 2008, 47, 10, 1489

    CrossRef

  34. 34
    Lars Klareskog, Johan Rönnelid, Karin Lundberg, Leonid Padyukov, Lars Alfredsson, Immunity to Citrullinated Proteins in Rheumatoid Arthritis, Annual Review of Immunology, 2008, 26, 1, 651

    CrossRef

  35. 35
    Andreea Ioan-Facsinay, Annemiek Willemze, David B. Robinson, Christine A. Peschken, Janet Markland, Diane van der Woude, Brenda Elias, Henri A. Ménard, Marianna Newkirk, Marvin J. Fritzler, René E. M. Toes, Tom W. J. Huizinga, Hani S. El-Gabalawy, Marked differences in fine specificity and isotype usage of the anti–citrullinated protein antibody in health and disease, Arthritis & Rheumatism, 2008, 58, 10
    Direct Link:
  36. 36
    Walther J. Venrooij, Albert J. W. Zendman, Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 36

    CrossRef

  37. 37
    K. N. Verpoort, E. A. M. Papendrecht-van der Voort, A. H. M. van der Helm-van Mil, C. M. Jol-van der Zijde, M. J. D. van Tol, J. W. Drijfhout, F. C. Breedveld, R. R. P. de Vries, T. W. J. Huizinga, R. E. M. Toes, Association of smoking with the constitution of the anti–cyclic citrullinated peptide response in the absence of HLA–DRB1 shared epitope alleles, Arthritis & Rheumatism, 2007, 56, 9
    Direct Link:
  38. 38
    Serena Bugatti, Veronica Codullo, Roberto Caporali, Carlomaurizio Montecucco, B cells in rheumatoid arthritis, Autoimmunity Reviews, 2007, 7, 2, 137

    CrossRef

  39. 39
    Serena Bugatti, Veronica Codullo, Roberto Caporali, Carlomaurizio Montecucco, B cells in rheumatoid arthritis, Autoimmunity Reviews, 2007, 6, 7, 482

    CrossRef

  40. 40
    Y. K. Onno Teng, E. W. Nivine Levarht, Mojtaba Hashemi, Ingeborg M. Bajema, René E. M. Toes, Tom W. J. Huizinga, Jacob M. van Laar, Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment, Arthritis & Rheumatism, 2007, 56, 12
    Direct Link:
  41. 41
    Cristiano Alessandri, Roberta Priori, Mariagrazia Modesti, Riccardo Mancini, Guido Valesini, The Role of Anti-Cyclic Cytrullinate Antibodies Testing in Rheumatoid Arthritis, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 45

    CrossRef

View Full Article (HTML) Get PDF (110K)